LIVEWIRE ERGOGENICS, INC. ANNOUNCES STRATEGIC DEVELOPMENT
AGREEMENTS AND APPOINTMENTS TO ADVISORY BOARD
Anaheim, CA -- July 25, 2017 -- InvestorsHub NewsWire
-- LiveWire Ergogenics, Inc. (OTC
PINK: LVVV), a company focused on research partnerships,
product development and commercialization of cannabinoid-based
products, today announced it has entered into development
agreements with seasoned horticulturists Kyle McKay and Jason
Olson. The company also announced their appointments to the newly
formed 7xPure Advisory and Compliance Board.
Mr. McKay and Mr. Olson will be responsible for providing
extensive cultivation expertise specifically in cannabis cloning to
provide proven and newly developed strains for research study
purposes and potential commercial development. Under the terms of
the development agreements, they will identify new varieties of
cannabis strains in an effort to provide greater efficacy when
targeting specific ailments. Together, they possess over 25 year of
experience in the industry and are extremely qualified to guide
LiveWires efforts to become a significant force in the cannabinoid
health and wellness industry. Their expertise in plant genetics and
modern horticulture technology, in combination with their track
record of growing successful strains makes them extremely qualified
to render the requisite services to Company
Bill Hodson, CEO of LiveWire Ergogenics states, Kyle and Jason
may be two of the most qualified developers I have met in this
space. They perfectly fit our strategy to advance our developments
with an experienced and highly regarded team with specific
disciplines to continue expanding our vertically integrated
network. We are aggressively positioning ourselves to take
advantage of new and commercially viable opportunities, initially
in the California cannabis space, with plans to expand. This
includes cloning, grow facilities, extraction and distribution, all
of which feeds our passion for innovative and high-quality product
development that will accelerate the building of a sustainable and
profitable business in a new and burgeoning cannabis market.
Messrs. McKay and Olson will also serve on the Livewire
Scientific Advisory Board currently being formed. Their passion for
pesticide-free, clean genetics and organic growth is also expected
to be a driving force in establishing the strict testing
requirements for LiveWires 7XPure Compliance and Verification
System currently in development. Livewire strives to establish its
7XPure Compliance and Verification System as the gold standard for
the entire industry.
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV)
is focused on identifying and monetizing current and future trends
in the health and wellness industry, derived from, or enhanced with
legal cannabis products. The Company is focused on establishing and
advancing research partnerships for specific ailments, cloning of
high-quality and organic cannabis strains to effectively address
these ailments, dosing verification of zero pesticide products for
quality brands and the general development and commercialization of
cannabinoid based products and services. The team at LiveWire
Ergogenics is committed to developing high-quality and organically
clean products and generate and execute innovative ideas for the
advancement of the company, its customers and the entire
industry.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements.
Forward-looking statements may include, without limitation,
financial projections, statements regarding the plans and
objectives of management for future operations, the development,
regulatory approvals and commercialization of the Companys
products, or any of the Companys other proposed products, systems
or services. Such forward-looking statements are not meant to
predict or guarantee actual results, performance, events or
circumstances and actual results may differ considerably. Factors
that may cause actual results to differ materially from any
projections or outlooks may include, without limitation, the
Companys inability to obtain additional financing to continue
operations, delays in the development of its products, the impact
of significant government regulation in the cannabis industry,
existing or increased competition, results of arbitration and
litigation, stock volatility and illiquidity, and the Companys
failure in general to implement the Companys business plans or
strategies. The Company assumes no obligation to update any
forward-looking statements to reflect any event or circumstance
that may arise after the date of this release.
INVESTOR CONTACT
EquiNet, LLC
Toll free: 877-964-6463
Direct: 858-264-6500
LIVEWIRE ERGOGENICS INC.
1600 North Kraemer Blvd.
Anaheim, CA 92806
714-740-5144
www.livewireergogenics.com
info@livewireergogenics.com
